CNS Long Call Strategy
CNS (Cohen & Steers, Inc.), in the Financial Services sector, (Asset Management industry), listed on NYSE.
Cohen & Steers, Inc. operates as a publicly traded holding company specializing in asset management. Through its various operating units, the firm delivers financial services to institutional investors, such as pension funds, university endowments, and charitable foundations. Its subsidiaries are tasked with managing bespoke client portfolios across equities, fixed income, multi-asset strategies, and commodities. Additionally, these subsidiaries develop and oversee a diverse range of investment vehicles, including mutual funds (focused on equity, fixed income, balanced, and multi-asset classes) and hedge funds. The company's global investment strategy, implemented via its affiliated entities, involves allocating capital in public equity, fixed income, and commodity markets. For its equity and fixed income allocations, the firm's affiliates specifically target businesses within the real estate industry (including REITs), infrastructure, and natural energy resources.
CNS (Cohen & Steers, Inc.) trades in the Financial Services sector, specifically Asset Management, with a market capitalization of approximately $4.36B, a trailing P/E of 25.98, a beta of 1.20 versus the broader market, a 52-week range of 58.39-86.56, average daily share volume of 300K, a public-listing history dating back to 2004, approximately 424 full-time employees. These structural characteristics shape how CNS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.20 places CNS roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. CNS pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a long call on CNS?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
CNS snapshot
As of August 14, 2026, spot at $84.74, ATM IV 31.70%, IV rank 3.70%, expected move 9.09%. The long call on CNS below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this long call structure on CNS specifically: CNS IV at 31.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a CNS long call, with a market-implied 1-standard-deviation move of approximately 9.09% (roughly $7.70 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CNS expiries trade a higher absolute premium for lower per-day decay. Position sizing on CNS should anchor to the underlying notional of $84.74 per share and to the trader's directional view on CNS stock.
CNS long call setup
The CNS long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CNS at $84.74 on that close, the first option leg uses a $84.74 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CNS chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CNS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $84.74 | N/A |
CNS long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
CNS long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on CNS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on CNS
Long calls on CNS express a bullish thesis with defined risk; traders use them ahead of CNS catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
CNS thesis for this long call
The market-implied 1-standard-deviation range for CNS extends from approximately $77.04 on the downside to $92.44 on the upside. A CNS long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current CNS IV rank near 3.70% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CNS at 31.70%. As a Financial Services name, CNS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CNS-specific events.
CNS long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CNS positions also carry Financial Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CNS alongside the broader basket even when CNS-specific fundamentals are unchanged. Long-premium structures like a long call on CNS are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current CNS chain quotes before placing a trade.
Frequently asked questions
- What is a long call on CNS?
- A long call on CNS is the long call strategy applied to CNS (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With CNS stock at $84.74 on the most recent close, the strikes shown on this page are snapped to the nearest listed CNS chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are CNS long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the CNS long call priced from the end-of-day chain at a 30-day expiry (ATM IV 31.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CNS long call?
- The breakeven for the CNS long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The CNS market-implied 1-standard-deviation expected move in the same options snapshot is approximately 9.09%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on CNS?
- Long calls on CNS express a bullish thesis with defined risk; traders use them ahead of CNS catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current CNS implied volatility affect this long call?
- CNS ATM IV is at 31.70% with IV rank near 3.70%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.